Trial Information

Summary: Type 2 Diabetes Research Study

A multicenter, randomized, double-blind, active controlled study to compare the effect of 24 weeks treatment with combination therapy of LAF237 and Pioglitazone to LAF237 monotherapy or pioglitazone monotherapy in drug naïve patients with Type 2 Diabetes.

For more information,

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:44:34 AM